StockData
Pure Bioscience, Inc. logo

Pure Bioscience, Inc. (PURE) income statement

PUREOTCMiscellaneous Chemical ProductsFiscal year ends July 31
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jul 31, 2026Last filing: 10-K on Oct 29, 2026Score 1/30
$0.07−0.01 (-12.10%)

Close on Oct 19, 2026Market cap $8.67MP/E –Yield –

Pure Bioscience, Inc. income statement

Ratios

Latest available, balances at Jul 31, 2026

Profitability, TTM

Gross margin
57.3%
Operating margin
-90.0%
Net margin
-107.3%
Return on equity, FY2026
43.1%

Financial strength

Current ratio
0.27
Debt to equity
–
Debt to assets
–
Cash to current liabilities
13.0%

Valuation

P/E ratio
–
Price to sales
3.75
Price to book
–
Dividend yield
–

See a number that looks wrong?